These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22892606)

  • 1. 25-gauge vitrectomy versus intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion: 1 year follow-up.
    Sato T; Sawada K; Iwahashi-Shima C; Bando H; Ikeda T; Emi K
    Ann Acad Med Singap; 2012 Jul; 41(7):294-9. PubMed ID: 22892606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion.
    Kwon SI; Kim YW; Bang YW; Lee JY; Park IW
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):5-9. PubMed ID: 23237542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion.
    Ramezani A; Esfandiari H; Entezari M; Moradian S; Soheilian M; Dehsarvi B; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1149-60. PubMed ID: 22331147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
    Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.
    Wu L; Arevalo JF; Roca JA; Maia M; Berrocal MH; Rodriguez FJ; Evans T; Costa RA; Cardillo J;
    Retina; 2008 Feb; 28(2):212-9. PubMed ID: 18301025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
    Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
    Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2009; 29(10):1396-403. PubMed ID: 19898177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
    Moon J; Kim M; Sagong M
    Eye (Lond); 2016 Aug; 30(8):1084-90. PubMed ID: 27229707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.
    Callizo J; Atili A; Striebe NA; Bemme S; Feltgen N; Hoerauf H; Bertelmann T
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):913-920. PubMed ID: 30610424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of serous retinal detachment in branch retinal vein occlusion and response after primary intravitreal bevacizumab injection.
    Poon YC; Chen CH; Kuo HK; Chen YJ; Wu PC; Chen YH; Lee JJ
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):319-24. PubMed ID: 23145863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study.
    Raizada S; Al Kandari J; Al Diab F; Al Sabah K; Kumar N; Mathew S
    Indian J Ophthalmol; 2015 Jun; 63(6):504-10. PubMed ID: 26265641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
    Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND
    Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).
    Moradian S; Faghihi H; Sadeghi B; Piri N; Ahmadieh H; Soheilian M; Dehghan MH; Azarmina M; Esfahani MR
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):193-200. PubMed ID: 21337043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.
    Farese E; Cennamo G; Velotti N; Traversi C; Rinaldi M; De Crecchio G
    Eur J Ophthalmol; 2014; 24(5):761-70. PubMed ID: 24585424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage.
    Zhao L; Li B; Feng K; Han L; Ma Z; Liu Y
    Curr Eye Res; 2015 Jul; 40(7):752-6. PubMed ID: 25330134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.